Home » Newsletters » BioWorld

BioWorld

Oct. 7, 1992

View Archived Issues

BOEHRINGER BUYS 6.8% OF NEORX

RAC APPROVES GENE THERAPY TRIAL FOR LUNG CANCER

NEW ROLE FOR MACROPHAGES IN LDL

PROGENICS GETS $50,000 GRANT

$450,000 GRANT FOR PHARMOS

FDA CERTIFIES MULTIPLE PEPTIDE

INTERNATIONAL MUREX TO CONSOLIDATE

LIGAND FILES FOR 3 MILLION-SHARE IPO

SENATE EXPECTED TO PASS USER FEES

ADVANCED TISSUE GETS SBIR GRANT

ABI, PERKIN-ELMER IN $330M MERGER

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026